Dai, Xing-Bin <br/><br/>
Reactivation of hepatitis B virus 40 months after discontinuation of rituximab maintenance treatment and 5 months after cessation of entecavir administration.  [electronic resource] 

 -  Clinics and research in hepatology and gastroenterology  Jun 2015 
 - e39-40 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>2210-741X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinre.2014.11.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Antiviral Agents--administration & dosage<br/>Fatal Outcome<br/>Female<br/>Guanine--adverse effects<br/>Hepatitis B--etiology<br/>Hepatitis B virus--drug effects<br/>Humans<br/>Rituximab--administration & dosage<br/>Time Factors<br/>Withholding Treatment